Identification of NUDT5 Inhibitors From Approved Drugs

Frontiers in Molecular Biosciences - Switzerland
doi 10.3389/fmolb.2020.00044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Identification of FDA-approved Drugs That Computationally Bind to MDM2

Chemical Biology and Drug Design
BiochemistryOrganic ChemistryDrug DiscoveryMolecular MedicinePharmacology
2012English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Identification of FDA Approved Drugs Targeting COVID-19 Virus by Structure-Based Drug Repositioning

2020English

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Scientific Reports
Multidisciplinary
2013English

Added Therapeutic Value of New Drugs Approved in Brazil From 2004 to 2016

Cadernos de Saude Publica
MedicineEnvironmentalPublic HealthOccupational Health
2019English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Pivotal Studies of Orphan Drugs Approved for Neurological Diseases

Annals of Neurology
Neurology
2009English

Approved Antiviral Drugs Over the Past 50 Years

Clinical Microbiology Reviews
ImmunologyEnvironmentalPublic HealthMicrobiologyMicrobiology EpidemiologyInfectious DiseasesOccupational Health
2016English

Synthetic Approaches to New Drugs Approved During 2016

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy